Author Archives: Center for Biotechnology

Kathera Bioscience Receives SBIR Phase I Fast Track Award To Advance Novel Drugs To Treat Life Threatening Fungal Infections

Posted on by

Kathera Bioscience Inc., a privately-held biotech startup was awarded a SBIR Fast Track grant with a value of up to $3,298,530 from the National Institute of Allergy and Infectious Diseases (NIAID) for its dihydrofolate reductase (DHFR) program. Kathera Bioscience was founded by CFB Advisor and Long Island BIoMentor Initiative Mentor Dr. Stephen Parent.

Kathera is developing novel therapeutics to treat fungal infections, a major cause of human disease with an estimated 11.5 million annual life-threatening infections globally, resulting in more than 1.5 million deaths. The award will fund selection of a lead series in the Phase 1 award and lead optimization in Phase 2. Read more about Kathera and the award here.

Funding Opportunity for SBU Researchers: Development and Commercialization of Bio-Based Technologies for Human Health 

Posted on by

The Center for Biotechnology on behalf of the Long Island Bioscience Hub is pleased to announce a request for proposals for our two-tiered technology development & commercialization program. Awards will be in two categories: Feasibility ($50k/12mo) and Proof of Concept ($100K/12 mo).  More information can be found thru this link (or view on CfB web-page)… 

Review the full funding program overview and proposal guidelines. 

Stony Brook University faculty and postdoctoral associates, alone or in partnership with companies or CFB-appointed BioEntrepreneurs-in-Residence (BEIRs), are eligible to apply. In all instances, the faculty member or post-doctoral associate must serve as the principal investigator, and the project must be executed on the academic campus at Stony Brook University.

Application Deadline: March 7, 2024 no later than 5pm.

Interested applicants are strongly recommended to connect with the Center for Biotechnology team before writing a full proposal and submission.  
Please contact Phuong Nguyen, PhD, at the Center for Biotechnology: phuong.t.nguyen@stonybrook.edu.

IBNY 08 Open Call for Applications

Posted on by

IndieBio NY is hosting an open call for consideration to be a part of its upcoming Spring 2024 Class 08 Cohort. If you are a founder building an early stage pre-seed biotech company that addresses a pressing human and planetary health problem, this may be for you.

Applications can be submitted at the link by January 19th, 2024. Selected companies will be notified as soon as possible and pitches will be scheduled for the first week of February with virtual and in person options available: https://airtable.com/app4sqweetYmYsYct/shrnu4JPt2y86CDtv

IndieBio is the world’s largest seed life sciences development program devoted to funding and building startups to solve humanity’s most pressing problems with life itself. Twice a year, IndieBio selects 10 to 15 early-stage companies across different sectors in the life sciences to partake in an intensive 4-month program in New York City.

Each team is provided with funding, a rent-free lab, co-working space, dedicated educational programming and mentorship, and access to IndieBio’s massive network of alumni, investors, entrepreneurs, press, and corporate partners. Learn more about IndieBio at https://indiebio.co/.

New York State Request for Proposals: Cell and Gene Therapy Hub on Long Island

Posted on by

New York State’s Governor Hochul has released a Request for Proposals for State-of-the-Art Cell and Gene Therapy Hub on Long Island to Transform the Field of Medical Research and Advance Life-Saving Cancer Treatments. More than $150 Million will be available from New York State to support the development of major life sciences hub. Full details and link to RFP here.